Sökresultat

A research study at Lund University shows that there is an association between selenium deficiency and an increased risk of developing heart failure. The risk is twice as high for individuals with low selenium levels. Heart failure is a common condition affecting 250 000 Swedes. In heart failure, the heart cannot pump enough blood into the body, and the disease is associated with a poor prognosis.

https://www.medicine.lu.se/article/link-between-selenium-deficiency-and-heart-failure - 2026-07-07

Researchers at Lund University have developed a technique for simultaneously measuring electrical signals from 128 areas of the brain in awake rats. They have then used the information to measure what happens to the neurons when the rats are given psychedelic drugs. The results show an unexpected and simultaneous synchronisation among neurons in several regions of the brain. In light of the develo

https://www.medicine.lu.se/article/how-psychedelic-drugs-affect-rats-brain - 2026-07-07

A new study from Lund University in Sweden raises questions about the efficacy of bariatric operations involving gastric bypass. The results show that the biggest metabolic changes happened directly after surgery. Just a year after the operation, the concentration of metabolites and fats had returned to almost the same levels as before the procedure. Previous research has shown that the majority o

https://www.medicine.lu.se/article/positive-metabolic-effects-gastric-bypass-disappear-quickly - 2026-07-07

As certain tumor cells are able to conceal themselves in the body, it often means that patients with aggressive cancers experience a recurrence of the cancer after treatment. By programming genetically modified killer immune cells to seek and destroy the hiding tumor cells and tumor stem cells, it is hoped that we can develop more effective treatment options. An international research project, wit

https://www.medicine.lu.se/article/eu-funding-killer-cells-fight-cancer - 2026-07-07

BRCA1 and BRCA2 are well-known breast cancer genes associated with a significantly increased risk of hereditary breast and ovarian cancer. However, there are an additional eleven genes associated with elevated risk for these types of cancer. A multi-year Swedish study now reveals that the proportion of women with genetically confirmed hereditary breast cancer doubled by including all genes in the

https://www.medicine.lu.se/article/breast-cancer-study-altered-guidelines-sweden - 2026-07-07

On September 28, the official launch of SciLifeLab Lund will take place in Forum Medicum. Lund is one of the four new sites that were established in 2022. The sites in Gothenburg, Linköping, Umeå and Lund are part of a major governmental investment in national research infrastructure. The vision is for Sweden to be a world-leading research nation in molecular life sciences. Site coordinator Esther

https://www.medicine.lu.se/article/kick-scilifelab-lund - 2026-07-07

Is it possible that a single biomarker can detect all types of diseases related to dopamine deficiency in the brain? Yes, that's what a research group in Lund is discovering. "We have observed that an enzyme in cerebrospinal fluid and in blood is a useful marker for identifying all types of Parkinson's-related diseases with high accuracy," says Oskar Hansson, who led the study. The marker in quest

https://www.medicine.lu.se/article/new-blood-marker-can-identify-parkinsonian-diseases-0 - 2026-07-07

Currently, a lot is known about which genes are responsible for our individual blood groups, however not much is understood about how and why the levels of the blood group molecules differ between one person and another. And this can be important for blood transfusion safety. Now a research group in Lund has developed a toolbox that finds the answer – and in doing so, has solved a 50-year-old myst

https://www.medicine.lu.se/article/new-bioinfomatics-pipeline-solves-50-year-old-blood-group-puzzle - 2026-07-07

An international consensus report on diabetes identifies the potential for diabetes screening, better classification of type 2 diabetes, and biomarkers that can predict cardiovascular disease. The report also highlights that more evidence is needed before it is possible to provide individualised treatment to all patients. The report is based on a large collaboration between 28 universities worldwi

https://www.medicine.lu.se/article/new-report-opportunities-and-challenges-precision-diabetes-medicine - 2026-07-07

A research group at Lund University has studied how a molecular sensor located in the blood vessel wall, controls how the vessel compensates for high blood pressure. As we age, the sensor deteriorates, which can worsen vascular damage caused by high blood pressure and consequently lead to secondary diseases affecting the heart, brain, or other organs. In mice, the researchers demonstrate that the

https://www.medicine.lu.se/article/how-your-blood-vessels-tolerate-high-blood-pressure - 2026-07-07

Filipe Pereira, professor of molecular medicine at Lund University, is awarded this year's Fernström prize for young, exceptionally promising, and successful researchers. He receives the award for his work on reprogramming blood cells and the development of immunotherapies based on this technology. It was a sheep that determined Filipe Pereira's career choice. He was in high school when he heard a

https://www.medicine.lu.se/article/filipe-pereira-awarded-eric-k-fernstrom-prize-young-researchers - 2026-07-07

Meet our scientist, Dr. Niklas Mattsson-Carlgren! He explains why studying biomarkers is essential to advancing Alzheimer’s research. Niklas Mattsson-Carlgren is part of the Clinical Memory Research group, a leading centre in the development and evaluation of novel biomarkers for Alzheimer’s disease. In this podcast episode, he discusses why biomarker research is key not only to detecting but also

https://www.multipark.lu.se/article/meet-our-scientists-podcast-niklas-mattsson-carlgren-about-biomarkers-and-future-alzheimers - 2026-07-07

With over 15 research groups dedicated to Alzheimer’s disease research, MultiPark’s goal is to understand the origins of the disease, develop early diagnostics, and improve treatments. The multidisciplinary approach sheds light on the disease from several angles, bridging basic research with clinical investigations. Here are five projects. September is World Alzheimer’s Month. Globally, around 40

https://www.multipark.lu.se/article/alzheimers-awareness-five-research-projects-shaping-future-understanding-diagnosis-and-care - 2026-07-07

For decades, large stretches of human DNA were dismissed as ‘junk’ and considered to serve no real purpose. In a new study in Cell Genomics, researchers at Lund University in Sweden show that the repetitive part of the human genome plays an active role during early brain development and may also be relevant for understanding brain diseases. DNA carries the complete set of instructions an organism

https://www.multipark.lu.se/article/why-repetitive-dna-matters-human-brain-evolution-and-disease - 2026-07-07

Enormous amounts of data about Alzheimer’s Disease have been generated from clinical studies so far. Still, the molecular drivers of Alzheimer’s Disease are largely unknown. With the TAU-TIME project, Jacob Vogel aims to advance knowledge by developing an AI tool that brings together known biological mechanisms with data from patients with the disease. Recent funding from the European Research Cou

https://www.multipark.lu.se/article/time-unite-lab-and-clinic-15-million-eu-build-ai-model-alzheimers-disease - 2026-07-07

Early diagnosis is key to receiving proper care and advancing research on future therapies for neurodegenerative diseases such as Parkinson’s and dementia with Lewy bodies. New research from Skåne University Hospital and Lund University shows that combining a simple smell test with advanced spinal fluid analysis can predict these diseases with high accuracy, while sparing nearly half of patients f

https://www.multipark.lu.se/article/smell-test-cuts-need-invasive-parkinsons-screening - 2026-07-07

Researchers at Lund University in Sweden have developed a digital cognitive test for diagnosing Alzheimer's disease that is intended for use in primary care. “This digital test, which patients perform on their own with minimal involvement from healthcare personnel, improves the primary care physician's ability to determine who should be further examined by blood tests for Alzheimer's pathology ear

https://www.multipark.lu.se/article/new-digital-cognitive-test-diagnosing-alzheimers-disease - 2026-07-07

What if brain diseases could be cured by turning on the proper genes? Meet our scientist, Professor Cecilia Lundberg! She explains how gene therapy may complement cell therapies to combat Parkinson’s disease. Cecilia Lundberg is head of the CNS Gene Therapy Research Group and has spent her whole career developing cutting-edge tools that may be used in future therapies to slow down or cure neurodeg

https://www.multipark.lu.se/article/meet-our-scientists-podcast-cecilia-lundberg-about-gene-workshop - 2026-07-07

Have you ever wondered what the journey of someone living with Parkinson’s disease looks like? Meet our scientist, Professor Per Odin! He shares his experiences of the bumpy road faced by patients he has supported over the years, both in healthcare and in research studies. Parkinson’s disease is a long, challenging course; one that science works tirelessly to understand, where halting neurodegener

https://www.multipark.lu.se/article/meet-our-scientists-podcast-odin-about-parkinsons-journey - 2026-07-07

In a study led by Lund University and the Amsterdam University Medical Center, researchers used PET to analyse aggregates of tau pathology in more than 12,000 people from all over the world. The study – the largest ever of its kind – examines the connection between genetic predisposition, gender and age in relation to tau pathology in Alzheimer’s disease. The study is published in Nature Neuroscie

https://www.multipark.lu.se/article/largest-ever-taupet-study-alzheimers-deepens-understanding-disease - 2026-07-07